New Key Statistics Module, Z-Score and F-Score
NAS:BRTX Key Ratios
| Market Cap $ M | 9.28 |
| Enterprise Value $ M | -1.61 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.56 |
| Price/Sales | 38.06 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -3.51 |
| Beneish M-Score | -5.65 |
| 10-y EBITDA Growth Rate % | 63.30 |
| 5-y EBITDA Growth Rate % | 73.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.11 |
| EV-to-EBITDA | 0.11 |
| PEG | -- |
| Shares Outstanding M | 6.77 |
| Net Margin (%) | -9,873.29 |
| Operating Margin % | -10,368.49 |
| Pre-tax Margin (%) | -9,873.29 |
| Quick Ratio | 10.72 |
| Current Ratio | 10.72 |
| ROA % (ttm) | -102.63 |
| ROE % (ttm) | -109.04 |
| ROIC % (ttm) | -1,076.37 |
| Dividend Yield % | -- |
| Altman Z-Score | -16.09 |
BRTX Number of Guru Trades
BRTX Volume of Guru Trades
Gurus Latest Trades with NAS:BRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BRTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioRestorative Therapies Inc Insider Transactions
No Available Data
News about NAS:BRTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers